Clinical trial
Overwhelming Post-Splenectomy Infections (OPSI) After Cytoreductive Surgery and Hyperthemic Intraperitoneal Chemotherapy: a Prospective Observational Study
NCT05718726 is registered in ClinicalTrials.gov with Hampshire Hospitals NHS Foundation Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Overwhelming Post-Splenectomy Infections (OPSI) After Cytoreductive Surgery and Hyperthemic Intraperitoneal Chemotherapy: a Prospective Observational Study
- Lead sponsor
- Hampshire Hospitals NHS Foundation Trust
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- March 25, 2021
- Completion date
- February 1, 2031
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
infection;post surg procedure, peritoneal cancer